Using fluorine to improve biomaterials and biotechnology
Official title: Harnessing the orthogonality of fluorine for advanced biomaterials and biotechnologies
Funded at University of California Los Angeles · NIH-11011906 · Data updated 2026-11-12
This study is exploring new ways to use special compounds to improve treatments and tests for diseases like cancer and tough infections, aiming to create personalized therapies that work better for each patient.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | May 1, 2025 |
| Project end | March 31, 2030 |
| Funding year | 2025 |
| Award (this year) | $468,872 |
| NIH project number | 1R35GM156610-01 |
| Project ID | NIH-11011906 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include patients with cancer, inflammatory diseases, or drug-resistant infections.
✕Less likely to help
Patients with non-complex or non-metabolic diseases may not benefit from this research.
What this research studies
This research focuses on the unique properties of fluorinated compounds to enhance medical therapies and diagnostics. By designing specialized molecules that can interact with perfluorinated compounds, the team aims to create new tools for detecting and treating diseases like cancer and drug-resistant infections. The approach involves developing nanoemulsions that can carry therapeutic agents and be tailored for individual patient needs. This innovative methodology could lead to more effective and personalized treatment options.
Why it matters
Potential benefit: If successful, this research could lead to advanced therapies and diagnostics that are more effective for patients with complex diseases.
How similar studies have gone: Other research has shown promise in using fluorinated compounds for medical applications, indicating a potential for success in this novel approach.
Where this research is happening
-
University of California Los Angeles
Los Angeles, United States Active
Researchers
- Principal investigator: Sletten, Ellen May — University of California Los Angeles
- Study coordinator: Sletten, Ellen May
Related research
Other NIH-funded projects on the same topics.
-
Understanding how genetic changes in blood cells relate to heart disease in people with HIV
A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.
-
Systems genetics of vascular smooth muscle phenotypes in heart disease
Aims to understand how genetic differences influence vascular smooth muscle cells to improve prevention and treatment of coronary artery disease.
-
Motivation for Alcohol Use in Humans and How It Can Be Measured
This grant explores how people are motivated to drink alcohol and tests a safe, controlled way to study that motivation to inform better treatments for alcohol use disorder.
-
Overcoming CAR T cell resistance with tumor-targeted IL-12 to boost anti-tumor immunity
Aims to make CAR T cell therapy work better for solid tumors by using tumor-focused IL-12 to boost the body’s attack on cancer.
-
PediCODE: A Biorepository and Consortium for CoDE - Congenital Diarrhea and Enteropathy
A nationwide effort to collect clinical data and patient-derived samples to uncover the genetic causes of congenital diarrhea and enteropathy and to build a resource that helps researchers study these diseases.
-
Mentor Moms+: a community-led plan to cut alcohol use and HIV risk during pregnancy in South Africa
A community-based program adapts a trusted peer-led model to help pregnant and lactating people reduce alcohol use and HIV risk in South Africa.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.